🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a non-interventional observational study with the primary objective...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-05
Trial ID
NCT05557656
Treatments Being Tested
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
The goal of this clinical trial is to demonstrate the non-inferiority of tr...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06992648
Treatments Being Tested
This study is a multicenter, prospective, randomized controlled Phase II cl...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital, 52 Fucheng Road
Start Date
2025-07-30
Trial ID
NCT06772233
Treatments Being Tested
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
Continuous dosing of BAY73-4506 in patients with advanced cancer...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT01117623
Treatments Being Tested
This study will evaluate the addition of regorafenib to standard of care tr...
Status
Completed
Location
Istituto Oncologico Veneto IRCCS
Start Date
2022-07-04
Trial ID
NCT06095375
Treatments Being Tested
The purpose of this trial is to quantitatively assess the average amount of...
Status
Completed
Location
Klinikum Kreuzschwestern Wels GmbH
Start Date
2015-01-20
Trial ID
NCT02347852
Treatments Being Tested
Multicenter double-blind placebo-controlled randomized Phase II study compa...
Status
Completed
Location
CHRU Besançon
Start Date
2019-05-15
Trial ID
NCT03793361
Treatments Being Tested
The focus of this study will be to investigate whether Regorafenib demonstr...
Status
Recruiting
Location
IRST Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
Start Date
2024-09-23
Trial ID
NCT06275919
Treatments Being Tested